Fate Therapeutics appoints Jamie Harrell as SVP of market development, commercial operations
FATE•Fate Therapeutics appointed Jamie Harrell senior vice president of market development and commercial operations, effective Oct. 12, 2026. He will lead commercial and market development strategy across autoimmunity and oncology as the company moves toward commercialization.
1. Commercial leadership appointment
Harrell will lead commercial and market development strategy across autoimmunity and oncology, including physician engagement tied to outpatient administration for off-the-shelf CAR T programs FT819 and FT839. He previously served as vice president of marketing and commercial operations at Aurinia Pharmaceuticals and held roles at Avalo Therapeutics, Covidien, MedImmune, Centocor and Rhone-Poulenc Rorer.
